RN7SL796P

Across TCGA pan-cancer cohorts, RN7SL796P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RN7SL796P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RN7SL796P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL796P expression acts as an unfavorable survival marker.

THCA and STAD are the cancer types where RN7SL796P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.240	0.931	<.001	36	view →
STAD	DFS	Tertile	All	0.299	0.561	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RN7SL796P–THCA (OS)

Open the THCA breakdown →